Omega Therapeutics Inc (OMGA)
1.96
-0.21
(-9.68%)
USD |
NASDAQ |
May 10, 16:00
1.955
0.00 (0.00%)
After-Hours: 20:00
Omega Therapeutics Debt to Equity Ratio: 0.4328 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.4328 |
| December 31, 2023 | 0.3255 |
| September 30, 2023 | 0.2612 |
| June 30, 2023 | 0.2081 |
| March 31, 2023 | 0.1622 |
| Date | Value |
|---|---|
| December 31, 2022 | 0.1881 |
| September 30, 2022 | 0.1489 |
| June 30, 2022 | 0.1264 |
| March 31, 2022 | 0.1096 |
| December 31, 2021 | 0.099 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.099
Minimum
Dec 2021
0.4328
Maximum
Mar 2024
0.2062
Average
0.1752
Median
Debt to Equity Ratio Benchmarks
| Fate Therapeutics Inc | 0.00 |
| Ocular Therapeutix Inc | 0.1629 |
| AnaptysBio Inc | 0.00 |
| Amneal Pharmaceuticals Inc | -41.31 |
| Stoke Therapeutics Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 183.68M |
| Total Liabilities (Quarterly) | 142.33M |
| Shareholders Equity (Quarterly) | 41.35M |
| Current Ratio | 2.872 |
| Net Debt Paydown Yield | 0.20% |